GEORGE F TIDMARSH
CIK 1287235 · President, CEO & Secretary · last filed 2025-02-13
GEORGE F TIDMARSH is a President, CEO & Secretary who has filed 55 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing shows the insider was granted $700 of REVBW on Feb 13, 2025. Across all open-market trades the lifetime net is +$961.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3
4
55
$961.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REVBW | Director | 268 | $0.01 | $3 | $389.1K | 12 | 2025-02-13 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 77,331 | $1.12 | $86.6K | $0 | 3 | 2019-09-23 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | President, CEO & Secretary | 1,285,895 | $6.22 | $8.00M | $552.2K | 35 | 2019-04-17 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | CSO and Head of R&D Operations | 40,000 | $1.03 | $41.2K | $20.1K | 3 | 2011-01-03 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-13 | REVBW | Grant (A) | +181 | $700 | EDGAR |
| 2023-12-12 | REVBW | Sell (S) | −27,771 | -$14.4K | EDGAR |
| 2023-10-18 | REVBW | Sell (S) | −1,845 | -$1.2K | EDGAR |
| 2023-10-17 | REVBW | Sell (S) | −10,957 | -$7.2K | EDGAR |
| 2023-10-02 | REVBW | Sell (S) | −1,429 | -$986 | EDGAR |
| 2023-09-28 | REVB | Notice (144) | −1,429 | -$986 | EDGAR |
| 2023-09-18 | REVBW | Sell (S) | −25,500 | -$18.9K | EDGAR |
| 2023-04-19 | REVBW | Buy (P) | +51,500 | $59.7K | EDGAR |
| 2023-04-18 | REVBW | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | REVBW | Buy (P) | +20,000 | $32.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.